Projects per year
Personal profile
Education
- 2004-2016 Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 1999-2001 M.S., School of Medicine, Taipei Medical University
- 1987-1994 M.D., School of Medicine, Taipei Medical College
Experience
- Attending, Department of Pathology, Taipei Municipal Wanfang Hospital
- Director, Department of Pathology, Taipei Municipal Wanfang Hospital
- 2022.08- Director, Department of Pathology, School of Medicine, College of Medicin,e Taipei Medical University
- 2019.08- Associate Professor, Department of Pathology, School of Medicine, College of Medicin,e Taipei Medical University
- 2014.08-2019.07 Assistant Professor, Department of Pathology, School of Medicine, Taipei Medical University
- 2001.08-2014.07 Instructor, Department of Pathology, School of Medicine, Taipei Medical University
- 1996.09-2002.06 Resident Physician, Taipei Medical College Hospital
- 1996.07-1996.08 Resident Physician, Chang Gung Memorial Hospital
Research Interests
- Brain cancer, prostate cancer, cancer of gastrointestinal tract, immunohistochemistry, molecular pathology
Fingerprint
Dive into the research topics where Wei-Yu Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 10 Finished
-
候選基因在子宮內膜異位、非癌性毛勒氏管組織，子宮內膜癌前病變和子宮內膜癌的表達(I/II)
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
候選基因在子宮內膜異位、非癌性毛勒氏管組織，子宮內膜癌前病變和子宮內膜癌的表達(I/II)
1/1/20 → 12/1/20
Project: B - Project of TMU › h - Higher Education Sprout Project
-
Targeting a Novel Neurotrophic Signaling Ngf-Chrm4 in Drug-Resistant Neuroendocrine Prostate Cancer
8/1/19 → 7/31/20
Project: A - Government Institution › b - Ministry of Science and Technology
-
北醫大的表基因轉譯工作組-檢測人類組織中表基因和表轉錄基因機制
1/1/19 → 12/1/19
Project: A - Government Institution › d - Ministry of Education
-
Targeting the Inflammation as a Novel Therapy for Neuroendocrine Prostate Cancer Determined by Zbtb46
8/1/18 → 7/1/19
Project: A - Government Institution › b - Ministry of Science and Technology
-
Targeting PKLR/MYCN/ROMO1 signaling suppresses neuroendocrine differentiation of castration-resistant prostate cancer
Chen, W. Y., Thuy Dung, P. V., Yeh, H. L., Chen, W. H., Jiang, K. C., Li, H. R., Chen, Z. Q., Hsiao, M., Huang, J., Wen, Y. C. & Liu, Y. N., Jun 2023, In: Redox Biology. 62, 102686.Research output: Contribution to journal › Article › peer-review
Open Access -
Annoying Psoriasis and Atopic Dermatitis: A Narrative Review
Chen, W. Y., Chen, S. C., Hsu, S. Y., Lin, Y. A., Shih, C. M., Huang, C. Y., Wang, K. H. & Lee, A. W., May 1 2022, In: International journal of molecular sciences. 23, 9, 4898.Research output: Contribution to journal › Review article › peer-review
Open Access5 Citations (Scopus) -
Feasibility of Breast Cancer Metastasis Assessment of Ex Vivo Sentinel Lymph Nodes through a p-H&E Optical Coherence Microscopic Imaging System
Lin, S. E., Chang, W. W., Hsiao, P. K., Hsieh, M. C., Chen, W. Y., Fang, C. L. & Tsai, C. C., Dec 2022, In: Cancers. 14, 24, 6081.Research output: Contribution to journal › Article › peer-review
Open Access -
PCK1 regulates neuroendocrine differentiation in a positive feedback loop of LIF/ZBTB46 signalling in castration-resistant prostate cancer
Wen, Y. C., Liu, C. L., Yeh, H. L., Chen, W. H., Jiang, K. C., Tram, V. T. N., Hsiao, M., Huang, J., Chen, W. Y. & Liu, Y. N., Mar 23 2022, In: British Journal of Cancer. 126, 5, p. 778-790 13 p.Research output: Contribution to journal › Article › peer-review
2 Citations (Scopus) -
Primary appendiceal diffuse large B-cell lymphoma initially presenting as acute appendicitis: A case report
Liu, K. Y., Wu, S. M., Chen, W. Y. & Chang, C. L., Apr 2022, In: International Journal of Surgery Case Reports. 93, 106933.Research output: Contribution to journal › Article › peer-review
Open Access
Datasets
-
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. (Contributor), Zeng, T. (Creator), Abou-Kheir, W. (Creator), Yeh, H. (Contributor), Yin, J. J. (Creator), Lee, Y. (Creator), Chen, W. (Creator) & Liu, Y. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4008787.v1, https://doi.org/10.6084%2Fm9.figshare.c.4008787.v1
Dataset
-
Additional file 1: of Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y. (Contributor), Zeng, T. (Creator), Abou-Kheir, W. (Creator), Yeh, H. (Contributor), Yin, J. J. (Creator), Lee, Y. (Creator), Chen, W. (Creator) & Liu, Y. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.5900626.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Disruption_of_ETV6_leads_to_TWIST1-dependent_progression_and_resistance_to_epidermal_growth_factor_receptor_tyrosine_kinase_inhibitors_in_prostate_cancer/5900626/1
Dataset